Skip to content

menu

Rothwell, Figg, Ernst & Manbeck, P.C. logo
HomeAboutContact
RF EMerge logo

A Resource for Innovators

Topics

GuidanceTrends & AnalysisLegal DevelopmentsSubscribe

Emerging Companies: Framework for Leveraging Your IP & Tech

By Dan Shores & Caitlin Wilmot on December 4, 2020
Posted in Featured, Guidance

Founders of technology-based companies often recognize very early on that their company’s IP and related technology comprise a significant or…
Continue Reading Emerging Companies: Framework for Leveraging Your IP & Tech

Digital security concept

Lessons Learned From Centripetal’s Multi-Billion Dollar Damages Award Against Cisco

By Anjali Jenna (AJ) Teigen & Aydin H. Harston on November 23, 2020
Posted in Guidance, Legal Developments

Centripetal Networks, Inc. (“Centripetal”), one of the fastest growing innovators in the cybersecurity space, leveraged its patent portfolio against Cisco…
Continue Reading Lessons Learned From Centripetal’s Multi-Billion Dollar Damages Award Against Cisco

World Economic Forum Releases Top 10 Emerging Technologies of 2020

By Dan Shores on November 10, 2020
Posted in Trends & Analysis

Quick heads up, the World Economic Forum released a Special Report covering what it considers to the the top 10…
Continue Reading World Economic Forum Releases Top 10 Emerging Technologies of 2020

Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?

By Dan Shores on November 9, 2020
Posted in Featured, Trends & Analysis

As Pfizer and BioNTech announced this week that results of their COVID-19 vaccine have exceeded expectations, the technology behind the…
Continue Reading Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?

Businessman Shredding Documents

Is it Time to Re-evaluate (or Create) Your Document Retention Policy?

By Dylan Haversack & Aydin H. Harston on November 6, 2020
Posted in Featured, Guidance, Legal Developments

In the fast-paced and dynamic environment of startup and emerging companies, standard operating procedures and compliance matters may often fall…
Continue Reading Is it Time to Re-evaluate (or Create) Your Document Retention Policy?

Minds Overlap - Male Open Female Closed

USPTO Report Shows Tremendous Growth in Patent Filings on Artificial Intelligence

By Jennifer B. Maisel on November 5, 2020
Posted in Featured, Trends & Analysis

At this point we have all heard how artificial intelligence (AI) will change the world, and many of us have…
Continue Reading USPTO Report Shows Tremendous Growth in Patent Filings on Artificial Intelligence

Coronavirus COVID-19 medical test vaccine research and development concept.

Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic

By Aydin H. Harston on November 1, 2020
Posted in Trends & Analysis

On October 22, 2020, Boston-based Atea Pharmaceuticals, Inc. (“Atea”) announced an agreement with Roche for the exclusive rights to research,…
Continue Reading Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic

Ryder Launches $50M Venture Fund for Supply Chain Startups

By Dan Shores on October 30, 2020
Posted in Featured, Trends & Analysis

This week, Ryder System, Inc. (NYSE: R), announced a new corporate venture capital fund called RyderVentures.

The fund seeks to…
Continue Reading Ryder Launches $50M Venture Fund for Supply Chain Startups

Key Considerations Regarding Early Disclosures and Patent Protection

By Dan Shores & Anjali Jenna (AJ) Teigen on October 18, 2020
Posted in Guidance

Founders routinely need to disclose their groundbreaking technologies to third party investors, suitors, collaborators, peers, consultants and others in order…
Continue Reading Key Considerations Regarding Early Disclosures and Patent Protection

Eli Lilly to Buy Disarm Therapeutics for $135M Plus Potentially $1B+

By Dan Shores on October 17, 2020
Posted in Trends & Analysis

Pharmaceutical giant Eli Lilly and Company will purchase four-year-old Disarm Therapeutics, a Cambridge-based biotechnology company, for $135 million up…
Continue Reading Eli Lilly to Buy Disarm Therapeutics for $135M Plus Potentially $1B+

Post navigation

 Newer PostsOlder Posts 
Rothwell, Figg, Ernst & Manbeck, P.C.
Subscribe to this Blog
Washington, DC
607 14th St. NW
Suite 800
Washington, DC 20005
202.783.6040
info@rfem.com
Boston
One Boston Place
Suite 2600
Boston, MA 02108
617.312.3101
info@rfem.com
RSS LinkedIn Twitter Facebook
Privacy PolicyDisclaimer

About Our Firm

To learn more about our firm and other practice areas, visit: www.rfem.com.

Rothwell Figg Blogs

  • Biosimilars Law Bulletin
  • Privacy Zone
  • PTAB Law Blog
Copyright © 2021, Rothwell, Figg, Ernst & Manbeck, P.C. All Rights Reserved.
Powered By LexBlog

We use cookies to enhance your user experience. By continuing to use this site you are giving your consent for us to use cookies. For more information, please see our Privacy Policy.

Agree